Giua, Corrado http://orcid.org/0000-0002-7400-056X
Romano, Flora http://orcid.org/0000-0003-1932-3515
Keber, Enrico http://orcid.org/0000-0002-3993-0438
Pellegrino, Paolo
Perez, Marcos III http://orcid.org/0000-0003-0624-0884
Uboldi, Maria Chiara http://orcid.org/0000-0003-3206-8264
Bastianini, Maria Luisa
Belei, Erika
Carpinella, Federica
Casu, Stefania
Cecchini, Cesare
Cossu, Pietro
Delitala, David
Demontis, Rita
Giusti, Elena
Fasciolo, Alessandro
Fimiani, Giuseppe
Floris, Nicolina
Fortini, Marco
Modugno, Michele
Onano, Enrico
Onnis, Carla
Palmas, Federico
Sequenza, Maria Josè
,
Funding for this research was provided by:
Sanofi
Article History
Accepted: 18 October 2023
First Online: 4 December 2023
Declarations
:
: C.G, E.K, F.R declare no conflict of interest. P.P., M.C. and M.P. are currently employees of Sanofi and may hold shares and/or stock options in the company. SGCP: None declared.
: This study was conducted according to the guidelines of the Declaration of Helsinki, and the protocol was approved by the Ethics Committees of the local health authorities [Azienda Sanitaria Locale (ASL)] overseeing the participating pharmacies. List of approvals with the relevant protocol numbers: Comitato Etico Regione Toscana Area Vasta Nord Ovest prot n 52552, Comitato Etico ATS Sardegna prot. no. 172/2019/CE, Comitato Etico ATS Sardegna prot. no. 189/2019/CE, Comitato Etico Lazio 2 prot. no. 0201651, Comitato Etico di Area Vasta Sud Est, prot. no. 159, Comitato Etico Lazio 2 prot. no. 0027005/2020, Comitato Etico di Bergamo prot no. 180/19, Comitato Etico Campania Nord registro CECN/1177, Comitato Etico Regionale della Liguria registro CER Liguria 232/2020 and Comitato Etico ATS Sardegna prot. no. 261/2020/CE.
: Informed consent was obtained from all participants of the study.
: Not applicable.
: Not applicable.